Developer docs
API playgroundTry for free, no card

Search company profiles

NEMO Lab

Full company profile

uuid002ec1y

Namestring
NEMO Lab
Legal namestring
NEMO LAB S.R.L.
Websiteurl
nemolab.it
Company typeenum
Private
Founded yearint
2020
Descriptiontext

NEMO Lab S.R.L. is an Italian technology hub, founded around 2019-2020, that designs and develops high-tech innovation projects applied to neuromuscular diseases such as ALS (SLA), SMA, and muscular dystrophies. The company operates approximately 1,500 square meters of laboratory space inside ASST Grande Ospedale Metropolitano Niguarda in Milan, structured as ten specialized labs covering orthoses and 3D printing (Ortho Lab, 3D Printing Lab), assistive robotics (Biorobotic Lab), voice and message banking (Voice Lab), movement analysis (Me-Mo Lab), augmentative and alternative communication via eye-tracking and brain-computer interfaces (AAC/Opto Lab), home accessibility and domotics (Home Lab), VR-based rehabilitation (Entertainment Lab), and IoT-enabled telemonitoring (Smart Health Innovation Lab).

The company's most technologically advanced commercial products are the NIA (Nemo Intelligence Assistant) telemonitoring platform — a modular system comprising a wearable device for vital sign capture, a CE Class I certified web portal, HL7-FHIR interoperability, and a Level 3 AI engine for clinical decision support — and the AIlay4Care platform, an integrated cloud-based 'Digital Ally' that combines VR rehabilitation, AI-driven health prediction, web-based diagnostic apps, and Generative AI-driven 3D-printed customized orthotics. Proprietary AI capabilities span vocal marker detection (with CAMELOT Biomedical Systems), predictive analytics on PROMs data, computer vision for movement analysis, and AI-assisted materials design.

NEMO Lab's business model is a mix of sponsored R&D and technology-transfer services for medtech companies (Sharebot, CAMELOT, SolidColor, Dico Technologies, Ortopedia Castagna), consulting and training services for healthcare providers and homecare operators (notably VIVISOL), collaborative research funded by EU and regional grants (most recently the PR MARCHE FESR 2021-2027 AIlay4Care project with a EUR 1.36M EU contribution), and direct clinical services (voice banking, home adaptation, mobility vehicle consulting, telemonitoring pilots) delivered at its Niguarda facility. The company is governed by a Board of Directors under Director General Stefano Regondi, with Emanuele Frontoni as Scientific Director and Luca Maria Munari as Health Director, and is institutionally tied to Fondazione Serena Onlus and the NeMO Clinical Centers network.

Short descriptiontext

NEMO Lab is an Italian technology hub that develops and applies AI, robotics, 3D printing, VR, and telemonitoring solutions to improve care for patients with neuromuscular diseases, operating specialized labs inside ASST Niguarda hospital in Milan.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMilano, Italy
HQ citystring
Milano
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
assistive healthcare technology, neuromuscular disease research, telemonitoring healthcare, 3D printed orthotics, rehabilitation technology
Industry3 codes
PRIMARYHLAFAFAH
Neurorehabilitation Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Post-Acute Care & Rehabilitation Facilities
SECONDARYHLAFAKAK
Neurodiagnostic Centers (EEG/EMG/NCS)
SECONDARYHLALAAAE
At-Home Lab Testing & Diagnostics-Integrated Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Assistive Healthcare Technology
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1R&D Project Services
TypeProfessional Services
Description

Sponsored research agreements with specialized companies, technology transfer projects, and R&D collaboration on neuromuscular disease technologies. Revenue generated through funded research projects and technology co-development.

2Consulting Services
TypeProfessional Services
Description

Specialized training courses on technology application in disease management and consulting for companies investing in healthcare. Direct service provision for home adaptation, mobility vehicle assessment, and voice banking.

nemolab.it
3EU/Regional Research Funding
TypeSubscription Recurring
Description

Collaborative industrial research and experimental development projects funded by regional and EU programs. AILAY4Care project budget of 1,889,891.57 EUR with 1,359,211.37 EUR contributed by PR MARCHE FESR 2021-2027.

nemolab.it
4Intellectual Property Licensing
TypeLicensing Royalties
Description

Protection and licensing of research patents developed in partnership with universities and research institutes.

nemolab.it
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 10 records shown
1Ortho Lab
Description

Laboratory focused on increasing the offer of orthoses and adaptive technologies for function, quality, comfort, aesthetic impact, hygienic management, cost and accessibility improvement.

+9 more records
Core offering1 text field

NEMO Lab is an Italian technology hub that designs and develops high-tech innovation projects applied to neuromuscular diseases. Operating through nine specialized laboratories (3D Printing, Biorobotic, Ortho, Home, Mobility, Me-Mo, Entertainment, AAC/Opto, Voice, and Smart Health Innovation), it delivers R&D services, digital health platforms, assistive devices, and direct patient services such as voice banking, smart-home adaptation, and vehicle accessibility assessments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • NIA telemonitoring system operational in Rome and Brescia pilot programs to reduce unnecessary clinical visits
+2 more records
Product overview1 text field

NEMO Lab is a technology hub comprising nine specialized high-tech research laboratories dedicated to developing innovative technology projects applied to neuromuscular diseases. The portfolio spans a modular suite of services organized across: Ortho Lab and 3D Printing Lab (custom orthoses via additive manufacturing), Biorobotic Lab (assistive robotics), Voice Lab (voice/message banking and AAC), Me-Mo Lab (movement and posture analysis), AAC/Opto Lab (eye-tracking and brain-computer interface communication), Home Lab (smart home accessibility), Entertainment Lab (VR-based rehabilitation), and Smart Health Innovation Lab (IoT telemonitoring). The two most technologically advanced products are the NIA telemonitoring platform (wearable + AI analytics + cloud portal) and the AIlay4Care integrated digital platform (VR rehabilitation + web app + Generative AI + 3D printing). Technology transfer strategies include sponsored research agreements, IP licensing, joint laboratories, and high-tech startup contributions.

Product and service8 records
1NIA (Nemo Intelligence Assistant)
CategoryDigital Health Platform
2AIlay4Care Platform
CategoryDigital Health Platform
3Voice and Message Banking Service
CategoryAssistive Communication Service
4Custom 3D Printed Orthoses
CategoryMedical Device / Orthotic
5Mobility Vehicle Adaptation Service
CategoryAccessibility Engineering Service
6Smart Home Adaptation Service
CategoryAccessibility Engineering Service
7Movement Analysis (Me-Mo Lab)
CategoryClinical Analysis Service
8VR-Based Rehabilitation (Entertainment Lab)
CategoryRehabilitation Service
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
1NET MEDICA ITALIA S.r.l.
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-05
Description

Partner in AILAY4Care project for developing integrated digital systems for neuromuscular and neurodegenerative disease treatment. Combined with NLAB Research Center, DEEP REALITY, and AIDAPT.

nemolab.it
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-11-05
Description

Partner in AILAY4Care project contributing VR rehabilitation technology for the integrated platform development.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-11-05
Description

Partner in AILAY4Care project for collaborative development of digital health solutions.

4Olmedo Vehicles S.p.A.
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-10-14
Description

Collaboration for vehicle adaptation consulting for people with disabilities. Olmedo, a leader in disability vehicle transport with a dedicated Mobility Division, provides expertise for vehicle modification assessments.

nemolab.it
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-09-19
Description

Collaboration on AI algorithms and vocal markers research for neuromuscular disease monitoring. Development of software for identifying vocal markers correlated with specific diseases and detecting predictive trends using machine learning techniques.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-09
Description

Academic partnership with Prof.ssa Serena Graziosi's research group for 3D printing materials research, including TPMS structure printing and characterization studies published in Additive Manufacturing journal.

7Dico Technologies S.r.l.
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-04-29
Description

R&D collaboration for testing and evaluating DICo 1000 device for Augmentative and Alternative Communication (AAC). The device enables communication for people unable to vocalize, particularly in intensive care settings.

nemolab.it
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-03-07
Description

Strategic collaboration to promote care models and appropriate technologies for effective home care continuity for neuromuscular disease patients after hospital discharge. VIVISOL, a leading European homecare company serving over 500,000 patients daily, brings expertise in managing healthcare and technological needs at patients' homes, including home oxygen therapy, mechanical ventilation, telemedicine, and assistive devices. NEMO Lab provides technological innovation capabilities and R&D expertise.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-03-06
Description

Partnership for prototyping customized solutions and developing new functional 3D-printed materials for neuromuscular and neurodegenerative diseases. Sharebot provides high-precision 3D printing technology expertise while NEMO Lab brings biomedical application knowledge for orthotic device development.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-10-26
Description

Technical partner for NIA telemonitoring system development. RiAtlas is a spin-off of the University of Salerno providing telemedicine technology solutions.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-10-23
Description

Open Accelerator program participation for Smart Health Innovation Lab. ZCube accelerates digital health startups with funding opportunities up to EUR 100,000.

12IPCB-CNR (Istituto per i polimeri, composti e biomateriali del Consiglio Nazionale delle Ricerche)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-07-16
Description

Institutional partnership for research, development, and technology transfer in innovative polymer materials and advanced manufacturing processes. Focus on Future Emerging Technologies in Advanced Materials for nanomedicine and health applications.

nemolab.it
13Ortopedia Castagna
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-06-22
Description

Four-year agreement dedicated to Ortho Lab for developing orthotic solutions. Ortopedia Castagna, established in 1947, specializes in restoring patient autonomy and independence through orthopedic devices.

nemolab.it
14Cluster Lombardo Scienze della vita
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-06-15
Description

Regional life sciences cluster partnership for developing innovative solutions for patients through competency integration.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-06-15
Description

Parent organization and clinical partner providing NeMO Clinical Centers for patient care and research collaboration. NEMO Lab was established in the tradition of multidisciplinary care for ALS, SMA, and muscular dystrophy patients.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Develops robotic exoskeletons (EksoNR, EksoUE) for rehabilitation and gait assistance in neurological conditions including stroke, MS, and spinal cord injury. Directly comparable to NEMO Lab's Biorobotic Lab and Mobility Lab given shared focus on powered orthoses and gait/standing restoration for neuromuscular populations.

TypeDirect peer
Description

Developer of exoskeleton systems (ReWalk Personal 6.0 and ReStore) for individuals with spinal cord injuries and stroke survivors. Direct peer to NEMO Lab's Biorobotic and Mobility Labs because both target lower-limb mobility restoration through robotic exoskeletons for neurological and neuromuscular conditions.

3Sword Health
TypeBroad incumbent
Description

Digital musculoskeletal (MSK) care platform combining AI, sensor technology, and virtual physical therapy for MSK conditions. A broader incumbent in digital rehabilitation; while their focus is MSK rather than NMD, the business model (digital therapy platform + clinicians + wearable data) is structurally analogous to NEMO Lab's NIA telemonitoring and VR rehab approaches.

4XRHealth
TypeDirect peer
Description

Operates VR-based telerehabilitation clinics reimbursed by payers for neurological and orthopedic conditions, pairing immersive experiences with remote clinician oversight. Direct peer to NEMO Lab's Entertainment Lab given parallel use of VR/AR for patient rehabilitation in hospital and home settings.

TypeEmerging player
Description

Provider of personalized synthetic voices (CereVoice) and voice banking services used to create custom AAC voices for patients at risk of speech loss. Directly comparable to NEMO Lab's Voice Lab voice/message banking service, both targeting preservation of personal vocal identity for AAC applications.

TypeDirect peer
Description

Manufacturer of AAC devices and speech-generating devices (e.g., Accent, NovaChat, ChatPlus) widely used by individuals with motor neuron disease. Directly comparable to NEMO Lab's AAC/Opto Lab given overlapping product category of communication aids for patients who lose verbal ability.

TypeDirect peer
Description

Global leader in eye-tracking-based augmentative and alternative communication (AAC) devices for individuals with communication impairments including ALS. Direct peer to NEMO Lab's AAC/Opto Lab given shared focus on eye-tracker and BCI-driven communication solutions for neuromuscular patients with speech loss.

TypeDirect peer
Description

Commercializes myoelectric arm braces (MyoPro) that restore arm and hand function for patients with neuromuscular weakness from stroke, ALS, and similar conditions. Directly comparable to NEMO Lab's Biorobotic Lab in applying assistive robotics to upper-limb mobility for neuromuscular patients.

9Andiamo Health
TypeEmerging player
Description

Provides 3D-printed orthotics and prosthetics, particularly for pediatric neuromuscular patients. Direct peer to NEMO Lab's 3D Printing Lab and Ortho Lab in applying additive manufacturing to produce customized orthoses for neuromuscular indications.

TypeDirect peer
Description

Penumbra's REAL Immersive System is an FDA-cleared, VR-based rehabilitation platform for neurological and musculoskeletal patients in clinical and home settings. Directly comparable to NEMO Lab's Entertainment Lab and AIlay4Care VR rehabilitation module given shared focus on immersive VR therapy for neuromuscular rehabilitation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NEMO Lab

Assistive Healthcare Technologynemolab.it

NEMO Lab is an Italian technology hub that develops and applies AI, robotics, 3D printing, VR, and telemonitoring solutions to improve care for patients with neuromuscular diseases, operating specialized labs inside ASST Niguarda hospital in Milan.

What NEMO Lab does

NEMO Lab S.R.L. is an Italian technology hub, founded around 2019-2020, that designs and develops high-tech innovation projects applied to neuromuscular diseases such as ALS (SLA), SMA, and muscular dystrophies. The company operates approximately 1,500 square meters of laboratory space inside ASST Grande Ospedale Metropolitano Niguarda in Milan, structured as ten specialized labs covering orthoses and 3D printing (Ortho Lab, 3D Printing Lab), assistive robotics (Biorobotic Lab), voice and message banking (Voice Lab), movement analysis (Me-Mo Lab), augmentative and alternative communication via eye-tracking and brain-computer interfaces (AAC/Opto Lab), home accessibility and domotics (Home Lab), VR-based rehabilitation (Entertainment Lab), and IoT-enabled telemonitoring (Smart Health Innovation Lab).

The company's most technologically advanced commercial products are the NIA (Nemo Intelligence Assistant) telemonitoring platform — a modular system comprising a wearable device for vital sign capture, a CE Class I certified web portal, HL7-FHIR interoperability, and a Level 3 AI engine for clinical decision support — and the AIlay4Care platform, an integrated cloud-based 'Digital Ally' that combines VR rehabilitation, AI-driven health prediction, web-based diagnostic apps, and Generative AI-driven 3D-printed customized orthotics. Proprietary AI capabilities span vocal marker detection (with CAMELOT Biomedical Systems), predictive analytics on PROMs data, computer vision for movement analysis, and AI-assisted materials design.

NEMO Lab's business model is a mix of sponsored R&D and technology-transfer services for medtech companies (Sharebot, CAMELOT, SolidColor, Dico Technologies, Ortopedia Castagna), consulting and training services for healthcare providers and homecare operators (notably VIVISOL), collaborative research funded by EU and regional grants (most recently the PR MARCHE FESR 2021-2027 AIlay4Care project with a EUR 1.36M EU contribution), and direct clinical services (voice banking, home adaptation, mobility vehicle consulting, telemonitoring pilots) delivered at its Niguarda facility. The company is governed by a Board of Directors under Director General Stefano Regondi, with Emanuele Frontoni as Scientific Director and Luca Maria Munari as Health Director, and is institutionally tied to Fondazione Serena Onlus and the NeMO Clinical Centers network.

NEMO Lab firmographics

Firmographics
Name
NEMO Lab
Legal name
NEMO LAB S.R.L.
Website
https://nemolab.it
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
NEMO Lab is an Italian technology hub that develops and applies AI, robotics, 3D printing, VR, and telemonitoring solutions to improve care for patients with neuromuscular diseases, operating specialized labs inside ASST Niguarda hospital in Milan.
Ownership category
akta.pro rank

NEMO Lab industry classification

Industry
Product category
Assistive Healthcare Technology
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAFAFAH
Neurorehabilitation Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Post-Acute Care & Rehabilitation Facilities
SECONDARYHLAFAKAK
Neurodiagnostic Centers (EEG/EMG/NCS)
SECONDARYHLALAAAE
At-Home Lab Testing & Diagnostics-Integrated Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms

Keywords

  • Assistive healthcare technology
  • Neuromuscular disease research
  • Telemonitoring healthcare
  • 3D printed orthotics
  • Rehabilitation technology

Where NEMO Lab is headquartered

Location

Headquarters

HQ city
Milano
HQ country
Italy
HQ region
Europe

Offices1 record

Markets served

NEMO Lab business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. R&D Project Services: Sponsored research agreements with specialized companies, technology transfer projects, and R&D collaboration on neuromuscular disease technologies. Revenue generated through funded research projects and technology co-development.
  2. Consulting Services: Specialized training courses on technology application in disease management and consulting for companies investing in healthcare. Direct service provision for home adaptation, mobility vehicle assessment, and voice banking.
  3. EU/Regional Research Funding: Collaborative industrial research and experimental development projects funded by regional and EU programs. AILAY4Care project budget of 1,889,891.57 EUR with 1,359,211.37 EUR contributed by PR MARCHE FESR 2021-2027.
  4. Intellectual Property Licensing: Protection and licensing of research patents developed in partnership with universities and research institutes.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

NEMO Lab product offering

Product offering

Core offering

NEMO Lab is an Italian technology hub that designs and develops high-tech innovation projects applied to neuromuscular diseases. Operating through nine specialized laboratories (3D Printing, Biorobotic, Ortho, Home, Mobility, Me-Mo, Entertainment, AAC/Opto, Voice, and Smart Health Innovation), it delivers R&D services, digital health platforms, assistive devices, and direct patient services such as voice banking, smart-home adaptation, and vehicle accessibility assessments.

Product overview

NEMO Lab is a technology hub comprising nine specialized high-tech research laboratories dedicated to developing innovative technology projects applied to neuromuscular diseases. The portfolio spans a modular suite of services organized across: Ortho Lab and 3D Printing Lab (custom orthoses via additive manufacturing), Biorobotic Lab (assistive robotics), Voice Lab (voice/message banking and AAC), Me-Mo Lab (movement and posture analysis), AAC/Opto Lab (eye-tracking and brain-computer interface communication), Home Lab (smart home accessibility), Entertainment Lab (VR-based rehabilitation), and Smart Health Innovation Lab (IoT telemonitoring). The two most technologically advanced products are the NIA telemonitoring platform (wearable + AI analytics + cloud portal) and the AIlay4Care integrated digital platform (VR rehabilitation + web app + Generative AI + 3D printing). Technology transfer strategies include sponsored research agreements, IP licensing, joint laboratories, and high-tech startup contributions.

Differentiator

Problem solved

Functional benefit

Brands

  • Ortho Lab: Laboratory focused on increasing the offer of orthoses and adaptive technologies for function, quality, comfort, aesthetic impact, hygienic management, cost and accessibility improvement.
  • Mobility Lab
  • Biorobotic Lab
  • Voice Lab
  • Me-Mo Lab
  • AAC/Opto Lab
  • Home Lab
  • Entertainment Lab
  • Smart Health Innovation Lab
  • 3D Printing Lab

Products and services

  • NIA (Nemo Intelligence Assistant)
  • AIlay4Care Platform
  • Voice and Message Banking Service
  • Custom 3D Printed Orthoses
  • Mobility Vehicle Adaptation Service
  • Smart Home Adaptation Service
  • Movement Analysis (Me-Mo Lab)
  • VR-Based Rehabilitation (Entertainment Lab)

Quantifiable outcome

  • NIA telemonitoring system operational in Rome and Brescia pilot programs to reduce unnecessary clinical visits
  • +2 more outcomes

Companies that use NEMO Lab

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

NEMO Lab technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature5 records

NEMO Lab partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered core and minor.

  • NET MEDICA ITALIA S.r.l.coreStrategic or Co-development Partner · 5 November 2024Partner in AILAY4Care project for developing integrated digital systems for neuromuscular and neurodegenerative disease treatment. Combined with NLAB Research Center, DEEP REALITY, and AIDAPT.
  • DEEP REALITY S.r.l.coreTechnology or Integration · 5 November 2024Partner in AILAY4Care project contributing VR rehabilitation technology for the integrated platform development.
  • AIDAPT S.r.l.coreTechnology or Integration · 5 November 2024Partner in AILAY4Care project for collaborative development of digital health solutions.
  • Olmedo Vehicles S.p.A.minorStrategic or Co-development Partner · 14 October 2022Collaboration for vehicle adaptation consulting for people with disabilities. Olmedo, a leader in disability vehicle transport with a dedicated Mobility Division, provides expertise for vehicle modification assessments.
  • CAMELOT Biomedical Systems S.r.l.coreTechnology or Integration · 19 September 2022Collaboration on AI algorithms and vocal markers research for neuromuscular disease monitoring. Development of software for identifying vocal markers correlated with specific diseases and detecting predictive trends using machine learning techniques.
  • Politecnico di MilanocoreStrategic or Co-development Partner · 9 September 2022Academic partnership with Prof.ssa Serena Graziosi's research group for 3D printing materials research, including TPMS structure printing and characterization studies published in Additive Manufacturing journal.
  • Dico Technologies S.r.l.coreTechnology or Integration · 29 April 2022R&D collaboration for testing and evaluating DICo 1000 device for Augmentative and Alternative Communication (AAC). The device enables communication for people unable to vocalize, particularly in intensive care settings.
  • VIVISOLcoreStrategic or Co-development Partner · 7 March 2022Strategic collaboration to promote care models and appropriate technologies for effective home care continuity for neuromuscular disease patients after hospital discharge. VIVISOL, a leading European homecare company serving over 500,000 patients daily, brings expertise in managing healthcare and technological needs at patients' homes, including home oxygen therapy, mechanical ventilation, telemedicine, and assistive devices. NEMO Lab provides technological innovation capabilities and R&D expertise.
  • SharebotcoreTechnology or Integration · 6 March 2022Partnership for prototyping customized solutions and developing new functional 3D-printed materials for neuromuscular and neurodegenerative diseases. Sharebot provides high-precision 3D printing technology expertise while NEMO Lab brings biomedical application knowledge for orthotic device development.
  • RiAtlascoreTechnology or Integration · 26 October 2021Technical partner for NIA telemonitoring system development. RiAtlas is a spin-off of the University of Salerno providing telemedicine technology solutions.
  • ZCube (Zambon Research Venture)minorStrategic or Co-development Partner · 23 October 2020Open Accelerator program participation for Smart Health Innovation Lab. ZCube accelerates digital health startups with funding opportunities up to EUR 100,000.
  • IPCB-CNR (Istituto per i polimeri, composti e biomateriali del Consiglio Nazionale delle Ricerche)coreStrategic or Co-development Partner · 16 July 2020Institutional partnership for research, development, and technology transfer in innovative polymer materials and advanced manufacturing processes. Focus on Future Emerging Technologies in Advanced Materials for nanomedicine and health applications.
  • Ortopedia CastagnacoreStrategic or Co-development Partner · 22 June 2020Four-year agreement dedicated to Ortho Lab for developing orthotic solutions. Ortopedia Castagna, established in 1947, specializes in restoring patient autonomy and independence through orthopedic devices.
  • Cluster Lombardo Scienze della vitaminorStrategic or Co-development Partner · 15 June 2020Regional life sciences cluster partnership for developing innovative solutions for patients through competency integration.
  • Fondazione Serena Onlus (Centro NEMO Italia)coreStrategic or Co-development Partner · 15 June 2020Parent organization and clinical partner providing NeMO Clinical Centers for patient care and research collaboration. NEMO Lab was established in the tradition of multidisciplinary care for ALS, SMA, and muscular dystrophy patients.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

NEMO Lab competitors and assessment

Company assessment

Direct peers

  • Ekso Bionics: Develops robotic exoskeletons (EksoNR, EksoUE) for rehabilitation and gait assistance in neurological conditions including stroke, MS, and spinal cord injury. Directly comparable to NEMO Lab's Biorobotic Lab and Mobility Lab given shared focus on powered orthoses and gait/standing restoration for neuromuscular populations.
  • ReWalk Robotics: Developer of exoskeleton systems (ReWalk Personal 6.0 and ReStore) for individuals with spinal cord injuries and stroke survivors. Direct peer to NEMO Lab's Biorobotic and Mobility Labs because both target lower-limb mobility restoration through robotic exoskeletons for neurological and neuromuscular conditions.
  • XRHealth: Operates VR-based telerehabilitation clinics reimbursed by payers for neurological and orthopedic conditions, pairing immersive experiences with remote clinician oversight. Direct peer to NEMO Lab's Entertainment Lab given parallel use of VR/AR for patient rehabilitation in hospital and home settings.
  • PRC-Saltillo: Manufacturer of AAC devices and speech-generating devices (e.g., Accent, NovaChat, ChatPlus) widely used by individuals with motor neuron disease. Directly comparable to NEMO Lab's AAC/Opto Lab given overlapping product category of communication aids for patients who lose verbal ability.
  • Tobii Dynavox: Global leader in eye-tracking-based augmentative and alternative communication (AAC) devices for individuals with communication impairments including ALS. Direct peer to NEMO Lab's AAC/Opto Lab given shared focus on eye-tracker and BCI-driven communication solutions for neuromuscular patients with speech loss.
  • Myomo: Commercializes myoelectric arm braces (MyoPro) that restore arm and hand function for patients with neuromuscular weakness from stroke, ALS, and similar conditions. Directly comparable to NEMO Lab's Biorobotic Lab in applying assistive robotics to upper-limb mobility for neuromuscular patients.
  • Penumbra (REAL Immersive System): Penumbra's REAL Immersive System is an FDA-cleared, VR-based rehabilitation platform for neurological and musculoskeletal patients in clinical and home settings. Directly comparable to NEMO Lab's Entertainment Lab and AIlay4Care VR rehabilitation module given shared focus on immersive VR therapy for neuromuscular rehabilitation.

Broad incumbents

  • Sword Health: Digital musculoskeletal (MSK) care platform combining AI, sensor technology, and virtual physical therapy for MSK conditions. A broader incumbent in digital rehabilitation; while their focus is MSK rather than NMD, the business model (digital therapy platform + clinicians + wearable data) is structurally analogous to NEMO Lab's NIA telemonitoring and VR rehab approaches.

Emerging players

  • CereProc: Provider of personalized synthetic voices (CereVoice) and voice banking services used to create custom AAC voices for patients at risk of speech loss. Directly comparable to NEMO Lab's Voice Lab voice/message banking service, both targeting preservation of personal vocal identity for AAC applications.
  • Andiamo Health: Provides 3D-printed orthotics and prosthetics, particularly for pediatric neuromuscular patients. Direct peer to NEMO Lab's 3D Printing Lab and Ortho Lab in applying additive manufacturing to produce customized orthoses for neuromuscular indications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

NEMO Lab social profiles

Digital presence

NEMO Lab financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NEMO Lab leadership team

Management profile

Number of profiles

Profiles3 records

NEMO Lab funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NEMO Lab M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NEMO Lab

What does NEMO Lab do?

NEMO Lab is an Italian technology hub that designs and develops high-tech innovation projects applied to neuromuscular diseases. Operating through nine specialized laboratories (3D Printing, Biorobotic, Ortho, Home, Mobility, Me-Mo, Entertainment, AAC/Opto, Voice, and Smart Health Innovation), it delivers R&D services, digital health platforms, assistive devices, and direct patient services such as voice banking, smart-home adaptation, and vehicle accessibility assessments.

Is NEMO Lab a public or private company?

NEMO Lab is a private company. It is classified as unknown and is currently operating.

When was NEMO Lab founded?

NEMO Lab was founded in 2020. It employs 11 to 50 people.

Where is NEMO Lab based?

NEMO Lab is headquartered in Milano, Italy, in the Europe region.

How does NEMO Lab make money?

Four revenue lines are on record. R&D Project Services are the primary driver. The others are consulting Services, EU/Regional Research Funding and intellectual Property Licensing.

Who are NEMO Lab's main competitors?

Direct peers on record are Ekso Bionics, ReWalk Robotics, XRHealth, PRC-Saltillo, Tobii Dynavox, Myomo and Penumbra (REAL Immersive System). Sword Health is listed as a broad incumbent. Emerging players are CereProc and Andiamo Health.

Does NEMO Lab have an API?

No public API is recorded for NEMO Lab.

What industry is NEMO Lab in?

NEMO Lab's product category is Assistive Healthcare Technology. Its primary akta.pro industry code is HLAFAFAH, Neurorehabilitation Centers, with a secondary code of HLAFAKAK, Neurodiagnostic Centers (EEG/EMG/NCS). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales